Young barley field. (Credit: Prof. Dr. Katharina Scherf)
Researchers Find Celiac-Linked Fragments in ‘Gluten-Free’ Barley Beers That Cleared Industry Safety Checks
In A Nutshell
- Seven of 21 gluten-free-labeled barley beers contained celiac-linked protein fragments despite passing standard safety testing.
- Standard industry tests missed 17 of the 44 fragments detected, which carry no chemical markers the tests are designed to find.
- Four gluten-free-labeled beers exceeded the EU’s legal gluten-free threshold when measured by one of the two standard tests.
- Researchers say follow-up studies measuring actual fragment concentrations are needed before the real-world risk to celiac patients can be determined.
For millions of Americans with celiac disease, finding a safe beer has long been a challenge. Barley-based beers labeled gluten-free seemed to offer a solution, but a new study raises serious questions about whether those labels can be fully trusted. Researchers found that standard industry tests used to verify gluten-free status may be missing protein fragments that survive the brewing process entirely.
Celiac disease is an immune condition affecting roughly 1 in 100 people worldwide. When someone with the condition consumes gluten, a family of proteins found in wheat, barley, and rye, the body mounts a damaging attack on the small intestine. Even trace amounts can cause real harm. Brewers have developed specialized processes to break down gluten in barley beer, making the final product theoretically safe. But the researchers behind this study wanted to know whether those processes were actually doing the job, and whether the tests used to verify safety were catching everything they should.
Published in Applied Food Research, the answer was largely no on both counts. Using a highly sensitive detection method, researchers found celiac-linked protein fragments in commercially available beers carrying gluten-free labels.
Four Gluten-Free Barley Beers Exceed the Legal Gluten Threshold
To check whether a beer qualifies as gluten-free, brewers rely on a type of test called an ELISA, a chemical detector that hunts for specific markers on gluten proteins. Those markers work well in whole foods, but fermented products like beer present a trickier problem. Brewing breaks gluten proteins down into smaller fragments, and those fragments may not carry the same markers the tests are built to recognize. The European Union sets the legal limit for gluten-free products at no more than 20 milligrams of gluten per kilogram. Labeling rules vary by country, and some jurisdictions only allow a “gluten-reduced” label when products are made from gluten-containing grains rather than inherently gluten-free ingredients.
Two widely used versions of this test exist, called R5 and G12, and each looks for different chemical markers. A beer could look clean on one and fail the other. That is exactly what the researchers found. When they tested 25 barley-based beers alongside a rice beer used as a control, four labeled gluten-free showed gluten levels of roughly 28 to 41 milligrams per kilogram by the R5 test, meaning they technically exceeded the legal threshold. The G12 test, meanwhile, flagged detectable gluten in some beers the R5 test had cleared.
A More Sensitive Tool Finds Celiac-Linked Fragments ELISA Tests Miss
Researchers then turned to a more sophisticated analytical technique called nanoLC-MS/MS, a high-powered method that separates and identifies individual protein fragments based on their mass. Rather than looking for specific chemical flags the way ELISA tests do, it can identify the precise structure of fragments and check whether those structures match celiac-linked sequences.
Across 21 commercially available gluten-free barley beers and four non-gluten-free beers, the technique identified 44 distinct celiac-linked protein fragments. Twenty-nine of those were found in beers carrying gluten-free labels, products that had already cleared standard safety testing.
Critically, 17 of the 44 celiac-linked fragments contained none of the chemical markers that either ELISA test is designed to find. From the perspective of standard testing, those fragments are effectively invisible.
Not every gluten-free beer tested showed a problem. Fourteen of the 21 gluten-free-labeled barley beers contained no detectable celiac-linked protein fragments. But seven of those labeled beers did carry at least one such fragment. One pilsner-style beer contained the highest count of any gluten-free beer tested: 21 celiac-linked fragments. One particular fragment turned up in every single beer that tested positive, and several others appeared repeatedly, suggesting they are especially resistant to the breakdown processes brewers use to remove gluten.
Gluten-Free Barley Beer Labels May Offer Less Certainty Than Assumed
Because the analysis focused on identifying which fragments were present rather than measuring precise amounts, researchers could not determine how much of any given fragment a consumer would actually be ingesting. Follow-up research measuring concentrations and assessing whether those amounts would actually cause harm in celiac patients is still needed.
Researchers also lacked access to information about each beer’s specific brewing methods, since those processes are typically proprietary. That made it impossible to determine which approaches do the best job of eliminating celiac-linked fragments, or why results varied so widely across similar products.
For the estimated 3 million Americans with celiac disease, many of whom may have turned to gluten-free barley beer as a safer option, the core takeaway is straightforward: standard tests were built to detect specific things, and what those tests cannot see, they cannot flag. Whether the celiac-linked fragments detected here translate to real-world harm remains an open question, but the gap in detection is not a minor technical footnote.
Disclaimer: This article is based on a published peer-reviewed study and is intended for informational purposes only. It is not intended as medical or dietary advice. People with celiac disease or gluten sensitivity should consult a qualified healthcare professional before making any changes to their diet.
Paper Notes
Study Limitations
Several important constraints shape how the results should be read. First, the study was qualitative rather than quantitative, meaning the researchers identified which celiac-linked protein fragments were present but did not measure their precise concentrations. Without that information, it is not possible to assess the actual clinical risk to celiac patients from consuming these beers. The authors also did not have access to information about the specific brewing methods used in the commercial beers tested, making it impossible to evaluate how different production processes influence the presence of those fragments. Additionally, the protein databases used to identify fragments may not fully cover all known gluten protein sequences, particularly highly repetitive ones, which could mean some fragments went undetected. The study also examined single bottles from one batch per beer, so results may not reflect batch-to-batch variability. The authors note that further breakdown of these fragments during digestion in the human body and their actual ability to trigger an immune response after consumption was not assessed and remains an open question.
Funding and Disclosures
This project received funding from the European Union’s Horizon 2020 research and innovation programme under the ERA-NET Cofund action No. 696296, through The Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL), and through the Federal Ministry of Education and Research Germany (BMBF), project no. 01EA2205A (ImmunoSafe-CeD). Measurements at the mass spectrometer were funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 445432254. The authors declare no competing financial interests. During preparation of the work, the first author used Microsoft 365 Copilot Chat to analyze paragraphs for refinement of phrasing, clarity, and consistency; the authors reviewed and edited all content and take full responsibility for the published article.
Publication Details
Authors: Eleonora Tissen, Sabrina Geisslitz, Barbara Maier, Katharina Anne Scherf | Institutions: Technical University of Munich, TUM School of Life Sciences, Professorship of Food Biopolymer Systems, Freising, Germany; Leibniz Institute for Food Systems Biology at the Technical University of Munich, Freising, Germany; Department of Bioactive and Functional Food Chemistry, Institute of Applied Biosciences, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany | Journal: Applied Food Research, Volume 6 (2026), Article 101952 | Paper Title: “Identification of celiac disease-active peptides in gluten-free barley beers by nanoLC-MS/MS” | DOI: https://doi.org/10.1016/j.afres.2026.101952 | Published: Available online April 1, 2026







